Wenbei Peng

893 total citations · 1 hit paper
18 papers, 581 citations indexed

About

Wenbei Peng is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wenbei Peng has authored 18 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wenbei Peng's work include Cancer Immunotherapy and Biomarkers (6 papers), Pleural and Pulmonary Diseases (4 papers) and MicroRNA in disease regulation (3 papers). Wenbei Peng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Pleural and Pulmonary Diseases (4 papers) and MicroRNA in disease regulation (3 papers). Wenbei Peng collaborates with scholars based in China and Macao. Wenbei Peng's co-authors include Qiong Zhou, Zi-Hao Wang, Pei Zhang, Xiang‐Ping Yang, Linlin Ye, Xuan Xiang, Yiran Niu, Xiao‐Shan Wei, Siyu Zhang and Qianqian Xue and has published in prestigious journals such as Frontiers in Immunology, Journal of Ethnopharmacology and Journal of Leukocyte Biology.

In The Last Decade

Wenbei Peng

17 papers receiving 575 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lactate in the tumour microenvironment: From immune modulation to therapy

2021 305 citations Zi-Hao Wang, Wenbei Peng et al. EBioMedicine profile →

Peers

Wenbei Peng

IMMUN

ONCOL

PRM

Ning Kang China

Mengxuan Yang China

Zhimeng Yao China

Haining Li China

Petya Apostolova Germany

Angela M. Araujo Spain

Norah Sadek United States

Buqing Sai China

Yusheng Lin China

Ning Kang China

Wenbei Peng

203 ×0.8

151 ×0.6

294 ×1.5

IMMUN

110 ×0.7

ONCOL

59 ×0.7

PRM

Citations per year, relative to Wenbei Peng Wenbei Peng (= 1×) peers Ning Kang

Countries citing papers authored by Wenbei Peng

Since Specialization

Citations

This map shows the geographic impact of Wenbei Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbei Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbei Peng more than expected).

Fields of papers citing papers by Wenbei Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenbei Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbei Peng. The network helps show where Wenbei Peng may publish in the future.

Co-authorship network of co-authors of Wenbei Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Wenbei Peng. A scholar is included among the top collaborators of Wenbei Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenbei Peng. Wenbei Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wang, Haolei, et al.. (2025). New advances of natural products in non-small cell lung cancer: From mechanisms to therapies. Journal of Ethnopharmacology. 346. 119636–119636. 2 indexed citations

Wei, Xiao‐Shan, Xuan Xiang, Haolei Wang, et al.. (2025). Tumor cell-intrinsic circular RNA circFNDC3B attenuates CD8+ T cells infiltration in non-small cell lung cancer. Communications Biology. 8(1). 711–711. 2 indexed citations

Ye, Linlin, Xuan Xiang, Zihao Wang, et al.. (2025). H3K18 lactylation in cancer-associated fibroblasts drives malignant pleural effusion progression via TNFR2+ Treg recruitment. Experimental & Molecular Medicine. 57(11). 2671–2685.

Xue, Qianqian, Wenbei Peng, Siyu Zhang, et al.. (2024). Lactylation-driven TNFR2 expression in regulatory T cells promotes the progression of malignant pleural effusion. Journal for ImmunoTherapy of Cancer. 12(12). e010040–e010040. 18 indexed citations

Xue, Qianqian, Wenbei Peng, Siyu Zhang, et al.. (2023). Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing. Frontiers in Immunology. 14. 1148061–1148061. 8 indexed citations

Ye, Linlin, Xiao‐Shan Wei, Yiran Niu, et al.. (2023). Circular RNA circFBXO7 attenuates non-small cell lung cancer tumorigenesis by sponging miR-296-3p to facilitate KLF15-mediated transcriptional activation of CDKN1A. Translational Oncology. 30. 101635–101635. 8 indexed citations

Peng, Wenbei, Linlin Ye, Qianqian Xue, et al.. (2023). Silencing of circCRIM1 Drives IGF2BP1-Mediated NSCLC Immune Evasion. Cells. 12(2). 273–273. 12 indexed citations

Zhang, Siyu, Wenbei Peng, Haolei Wang, et al.. (2023). C1q⁺ tumor-associated macrophages contribute to immunosuppression through fatty acid metabolic reprogramming in malignant pleural effusion. Journal for ImmunoTherapy of Cancer. 11(8). e007441–e007441. 40 indexed citations

Xiang, Xuan, Yiran Niu, Zi-Hao Wang, et al.. (2022). Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment. Cytokine & Growth Factor Reviews. 67. 35–48. 63 indexed citations

10.

Wang, Zi-Hao, Pei Zhang, Yiheng Du, et al.. (2022). High-risk early-stage lung adenocarcinoma patients are identified by an immune-related circadian clock gene signature. Journal of Thoracic Disease. 14(10). 3748–3761. 2 indexed citations

11.

Wang, Zi-Hao, Pei Zhang, Wenbei Peng, et al.. (2022). Altered phenotypic and metabolic characteristics of FOXP3 ⁺ CD3 ⁺ CD56 ⁺ natural killer T (NKT)-like cells in human malignant pleural effusion. OncoImmunology. 12(1). 2160558–2160558. 46 indexed citations

12.

Wei, Xiao‐Shan, Xu Wang, Linlin Ye, et al.. (2021). Pleural effusion as an indicator for the poor prognosis of COVID‐19 patients. International Journal of Clinical Practice. 75(6). e14123–e14123. 14 indexed citations

13.

Wang, Zi-Hao, Wenbei Peng, Pei Zhang, Xiang‐Ping Yang, & Qiong Zhou. (2021). Lactate in the tumour microenvironment: From immune modulation to therapy. EBioMedicine. 73. 103627–103627. 305 indexed citations breakdown →

14.

Wang, Zi-Hao, Pei Zhang, Xuan Xiang, et al.. (2021). Development and Validation of a Prognostic Autophagy-Related Gene Pair Index Related to Tumor-Infiltrating Lymphocytes in Early-Stage Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 719011–719011. 5 indexed citations

15.

Niu, Yiran, Linlin Ye, Wenbei Peng, et al.. (2021). IL-26 promotes the pathogenesis of malignant pleural effusion by enhancing CD4+IL-22+ T-cell differentiation and inhibiting CD8+ T-cell cytotoxicity. Journal of Leukocyte Biology. 110(1). 39–52. 16 indexed citations

16.

Ye, Linlin, Wenbei Peng, Yiran Niu, et al.. (2020). Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis. Annals of Translational Medicine. 8(24). 1647–1647. 25 indexed citations

17.

Niu, Yiran, Jingyuan Liu, Xiao‐Shan Wei, et al.. (2019). Interleukin-26 upregulates interleukin-22 production by human CD4+ T cells in tuberculous pleurisy. Journal of Molecular Medicine. 97(5). 619–631. 10 indexed citations

18.

Gu, Yajia, et al.. (2014). MRI appearances of stage IE/IIE extranodal NK/T-cell lymphoma, nasal type, in the upper aerodigestive tract.. PubMed. 18(3). 404–12. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact